ARTICLE | Clinical News
Zeffix lamivudine 3TC nucleotide analog regulatory update
August 9, 1999 7:00 AM UTC
The European Commission granted European marketing approval for Zeffix to treat chronic hepatitis B. BCHE will receive royalties on European sales from partner Glaxo Wellcome plc (London, U.K.). ...